|
US7276497B2
(en)
*
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
CN101098854B
(zh)
|
2004-07-23 |
2012-12-05 |
恩多塞特公司 |
二价连接体及其轭合物
|
|
NZ595430A
(en)
|
2005-08-24 |
2013-05-31 |
Immunogen Inc |
Process for preparing maytansinoid antibody conjugates
|
|
NZ599239A
(en)
|
2007-03-14 |
2013-10-25 |
Endocyte Inc |
Binding ligand linked drug delivery conjugates of tubulysins
|
|
CA2680237C
(en)
|
2007-03-27 |
2018-11-06 |
Sea Lane Biotechnologies, Llc |
Constructs and libraries comprising antibody surrogate light chain sequences
|
|
US9138484B2
(en)
|
2007-06-25 |
2015-09-22 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CN104524592B
(zh)
|
2008-04-30 |
2018-06-05 |
伊缪诺金公司 |
交联剂和它们的用途
|
|
CN102083461B
(zh)
|
2008-04-30 |
2014-09-17 |
伊缪诺金公司 |
有效的偶联物和亲水性连接体
|
|
US20120128671A1
(en)
|
2009-05-13 |
2012-05-24 |
Lawrence Horowitz |
Neutralizing molecules to influenza viruses
|
|
AU2015201534B2
(en)
*
|
2009-06-03 |
2016-11-24 |
Immunogen, Inc. |
Conjugation methods
|
|
KR101947176B1
(ko)
|
2009-06-03 |
2019-02-12 |
이뮤노젠 아이엔씨 |
접합 방법
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
FR2949469A1
(fr)
*
|
2009-08-25 |
2011-03-04 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application en therapeutique
|
|
CA2809819A1
(en)
|
2009-09-09 |
2011-03-17 |
Centrose, Llc |
Extracellular targeted drug conjugates
|
|
TW201117814A
(en)
*
|
2009-10-02 |
2011-06-01 |
Sanofi Aventis |
New maytansinoids and the use of said maytansinoids to prepare conjugates with an antibody
|
|
JP2013506709A
(ja)
*
|
2009-10-06 |
2013-02-28 |
イミュノジェン・インコーポレーテッド |
有効なコンジュゲートおよび親水性リンカー
|
|
SMT201700139T1
(it)
|
2010-02-24 |
2017-05-08 |
Immunogen Inc |
Immunoconiugati contro il recettore 1 del folato e relativi usi
|
|
MY177062A
(en)
|
2010-03-12 |
2020-09-03 |
Debiopharm Int Sa |
Cd37-binding molecules and immunoconjugates thereof
|
|
FR2963007B1
(fr)
|
2010-07-26 |
2013-04-05 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application therapeutique
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
CN103328505B
(zh)
|
2010-10-29 |
2015-12-02 |
伊缪诺金公司 |
非拮抗性egfr结合分子及其免疫偶联物
|
|
EP2632490A4
(en)
|
2010-10-29 |
2014-10-22 |
Immunogen Inc |
NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF
|
|
MX2013005046A
(es)
|
2010-11-03 |
2013-12-12 |
Immunogen Inc |
Agentes citotoxicos que comprenden nuevos derivados de ansamitocina.
|
|
EP2640727B1
(en)
*
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
KR101959578B1
(ko)
|
2010-12-09 |
2019-03-18 |
이뮤노젠 아이엔씨 |
하전된 가교제의 제조방법
|
|
SMT201900181T1
(it)
|
2011-02-15 |
2019-05-10 |
Immunogen Inc |
Metodi di preparazione di coniugati
|
|
JP2014510080A
(ja)
*
|
2011-03-09 |
2014-04-24 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
EA201991268A3
(ru)
|
2011-03-29 |
2020-01-31 |
Иммуноджен, Инк. |
Получение конъюгатов "майтансиноид-антитело" одностадийным способом
|
|
WO2012135517A2
(en)
|
2011-03-29 |
2012-10-04 |
Immunogen, Inc. |
Preparation of maytansinoid antibody conjugates by a one-step process
|
|
CN114441757A
(zh)
|
2011-04-01 |
2022-05-06 |
伊缪诺金公司 |
用于增加folr1癌症治疗的功效的方法
|
|
US20120282282A1
(en)
*
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
TWI598363B
(zh)
|
2011-04-21 |
2017-09-11 |
必治妥美雅史谷比公司 |
拮抗ｃｄ４０之抗體多肽
|
|
BR112013031819B1
(pt)
|
2011-06-10 |
2022-05-03 |
Mersana Therapeutics, Inc |
Suporte polimérico, composição farmacêutica, composto, e, uso do suporte
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
WO2013016714A1
(en)
|
2011-07-28 |
2013-01-31 |
Sea Lane Biotechnologies |
Sur-binding proteins against erbb3
|
|
AU2012340686A1
(en)
|
2011-11-21 |
2014-06-19 |
Immunogen, Inc. |
Method of treatment of tumors that are resistant to EGFR therapies by EGFR antibody cytotoxic agent conjugate
|
|
US9975956B2
(en)
|
2011-12-22 |
2018-05-22 |
I2 Pharmaceuticals, Inc. |
Surrogate binding proteins which bind DR4 and/or DR5
|
|
BR112014013135A2
(pt)
*
|
2012-01-27 |
2017-12-05 |
Hoffmann La Roche |
composto, composição farmacêutica, método para o tratamento da inflamação, uso de um composto e invenção
|
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
MX362514B
(es)
|
2012-08-31 |
2019-01-22 |
Immunogen Inc |
Kits y ensayos de diagnostico para la deteccion del receptor 1 de folato.
|
|
WO2014055842A1
(en)
*
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
HK1213288A1
(zh)
|
2012-10-04 |
2016-06-30 |
Immunogen, Inc. |
使用pvdf膜純化細胞結合劑細胞毒性劑綴合物
|
|
US9662402B2
(en)
|
2012-10-16 |
2017-05-30 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
US20150290342A1
(en)
*
|
2012-10-24 |
2015-10-15 |
Polytherics Limited |
Drug-protein conjugates
|
|
NO2789793T3
(enExample)
|
2012-10-24 |
2018-01-27 |
|
|
|
JP6133431B2
(ja)
|
2012-11-24 |
2017-05-24 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
親水性連結体及び薬物分子と細胞結合分子との共役反応における親水性連結体の使用
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
CN104530235A
(zh)
|
2012-12-21 |
2015-04-22 |
百奥泰生物科技(广州)有限公司 |
一种抑制肿瘤生长的抗体药物衍生物及其制备方法和用途
|
|
CN103333179B
(zh)
*
|
2012-12-21 |
2017-06-16 |
百奥泰生物科技(广州)有限公司 |
类美登素衍生物及其制备方法和用途
|
|
FR3002454B1
(fr)
*
|
2013-02-26 |
2015-04-10 |
Commissariat Energie Atomique |
Composition immunogene sous forme d'emulsion
|
|
US9968673B2
(en)
*
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
|
EP2961434A2
(en)
*
|
2013-02-28 |
2016-01-06 |
ImmunoGen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
AU2014228489B2
(en)
|
2013-03-15 |
2018-11-15 |
Zymeworks Bc Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
CA2902872A1
(en)
|
2013-03-15 |
2014-09-18 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
MY192404A
(en)
*
|
2013-05-02 |
2022-08-19 |
Hoffmann La Roche |
Combination therapy of an afucosylated cd20 antibody with a cd22 antibody-drug conjugate
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
TWI641620B
(zh)
*
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
MX373528B
(es)
|
2013-08-26 |
2020-04-21 |
Regeneron Pharma |
Composiciones farmacéuticas que contienen diasterómeros macrólidos, métodos para su síntesis y usos terapéuticos.
|
|
SG11201601037YA
(en)
|
2013-08-30 |
2016-03-30 |
Immunogen Inc |
Antibodies and assays for detection of folate receptor 1
|
|
SG11201600645SA
(en)
|
2013-09-05 |
2016-03-30 |
Jackson Lab |
Compositions for rna-chromatin interaction analysis and uses thereof
|
|
SG10201907042PA
(en)
|
2013-10-08 |
2019-09-27 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
ES2754397T3
(es)
|
2013-10-11 |
2020-04-17 |
Asana Biosciences Llc |
Conjugados de proteína-polímero-fármaco
|
|
KR102087850B1
(ko)
*
|
2013-10-11 |
2020-03-12 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-고분자-약물 접합체
|
|
CN103483357B
(zh)
*
|
2013-10-12 |
2015-11-18 |
齐鲁制药有限公司 |
一种抗体-美登素偶联物的中间体新晶型及其制备方法
|
|
WO2015081857A1
(en)
*
|
2013-12-02 |
2015-06-11 |
Hong Kong Baptist University |
Anticancer maytansinoids with two fused macrocyclic rings
|
|
KR102384740B1
(ko)
|
2013-12-27 |
2022-04-07 |
자임워크스 인코포레이티드 |
약물 접합체를 위한 설폰아마이드-함유 연결 시스템
|
|
JP2017510548A
(ja)
*
|
2014-01-29 |
2017-04-13 |
シャンハイ ヘンルイ ファーマスーティカル カンパニー リミテッドＳｈａｎｇｈａｉ Ｈｅｎｇｒｕｉ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｃｏ．， Ｌｔｄ． |
リガンド‐細胞傷害性薬物抱合体、その製造方法、およびその用途
|
|
HRP20191335T1
(hr)
|
2014-03-11 |
2019-10-18 |
Regeneron Pharmaceuticals, Inc. |
Anti-egfrviii antitijela i njihove primjene
|
|
CN106715453B
(zh)
|
2014-03-24 |
2021-04-30 |
哥伦比亚大学董事会 |
用于生产带标签的核苷酸的化学方法
|
|
CN106856656B
(zh)
*
|
2014-04-29 |
2021-01-26 |
启德医药科技（苏州）有限公司 |
一种稳定型抗体药物耦联物及其制备方法和用途
|
|
WO2016001485A1
(en)
|
2014-06-30 |
2016-01-07 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
JP6602834B2
(ja)
|
2014-06-30 |
2019-11-06 |
ターベダ セラピューティクス インコーポレイテッド |
標的化コンジュゲートならびにその粒子及び製剤
|
|
CA2958882A1
(en)
|
2014-09-02 |
2016-03-10 |
Immunogen, Inc. |
Methods for formulating antibody drug conjugate compositions
|
|
US9381256B2
(en)
|
2014-09-03 |
2016-07-05 |
Immunogen, Inc. |
Cytotoxic benzodiazepine derivatives
|
|
SG11201701565PA
(en)
*
|
2014-09-03 |
2017-03-30 |
Immunogen Inc |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
MX2017002758A
(es)
|
2014-09-03 |
2017-10-20 |
Immunogen Inc |
Derivados de benzodiazepina citotoxicos.
|
|
RS62860B1
(sr)
|
2014-09-17 |
2022-02-28 |
Zymeworks Inc |
Citotoksična i antimitotička jedinjenja, i postupci upotrebe istih
|
|
BR112017020149A8
(pt)
|
2015-03-27 |
2023-05-02 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados dos mesmos e métodos de uso
|
|
JP7028648B2
(ja)
|
2015-05-04 |
2022-03-02 |
サイトメックス セラピューティクス インコーポレイテッド |
抗ｃｄ１６６抗体、活性化可能抗ｃｄ１６６抗体、およびその使用方法
|
|
EP3308801A4
(en)
*
|
2015-06-09 |
2019-02-27 |
XDCExplorer (Shanghai) Co., Ltd. |
ANTIBODY-ACTIVE CONJUGATE, INTERMEDIATE PRODUCT, METHOD OF MANUFACTURE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
|
|
HUE052616T2
(hu)
|
2015-06-29 |
2021-05-28 |
Immunogen Inc |
Ciszteinmódosított antitestek konjugátumai
|
|
JP6700321B2
(ja)
*
|
2015-07-04 |
2020-05-27 |
ハンジョウ ディーエーシー バイオテック シーオー．，エルティディ．Ｈａｎｇｚｈｏｕ Ｄａｃ Ｂｉｏｔｅｃｈ Ｃｏ．，Ｌｔｄ． |
細胞結合分子の特異的共役体
|
|
CN107849131A
(zh)
|
2015-07-06 |
2018-03-27 |
瑞泽恩制药公司 |
多特异性抗原结合分子及其用途
|
|
EP3325483B1
(en)
|
2015-07-21 |
2019-10-02 |
ImmunoGen, Inc. |
Methods of preparing cytotoxic benzodiazepine derivatives
|
|
EP3331569A1
(en)
|
2015-08-07 |
2018-06-13 |
Gamamabs Pharma |
Antibodies, antibody drug conjugates and methods of use
|
|
JP6880006B2
(ja)
|
2015-09-17 |
2021-06-02 |
イミュノジェン， インコーポレイテッド |
抗ｆｏｌｒ１免疫複合体を含む治療組み合わせ
|
|
CN108473538B
(zh)
|
2015-10-28 |
2022-01-28 |
塔弗达治疗有限公司 |
Sstr靶向缀合物及其颗粒和制剂
|
|
WO2017083403A1
(en)
|
2015-11-10 |
2017-05-18 |
Children's Research Institute, Children's National Medical Center |
Echinomycin formulation, method of making and method of use thereof
|
|
JP2019501139A
(ja)
|
2015-11-25 |
2019-01-17 |
イミュノジェン・インコーポレーテッド |
医薬製剤及びその使用
|
|
MA43416A
(fr)
|
2015-12-11 |
2018-10-17 |
Regeneron Pharma |
Méthodes pour ralentir ou empêcher la croissance de tumeurs résistantes au blocage de l'egfr et/ou d'erbb3
|
|
EA039072B9
(ru)
|
2016-01-25 |
2022-02-04 |
Регенерон Фармасьютикалз, Инк. |
Производные майтанзиноида, их конъюгаты и способы применения
|
|
PE20181953A1
(es)
*
|
2016-03-02 |
2018-12-17 |
Eisai Randd Man Co Ltd |
Conjugados de anticuerpo y farmaco basados en eribulina y metodos para su uso
|
|
CN119264413A
(zh)
*
|
2016-03-07 |
2025-01-07 |
韩美药品株式会社 |
聚乙二醇衍生物及其用途
|
|
EP3448891A1
(en)
|
2016-04-28 |
2019-03-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
|
WO2017197045A1
(en)
|
2016-05-11 |
2017-11-16 |
Movassaghi Mohammad |
Convergent and enantioselective total synthesis of communesin analogs
|
|
UY37278A
(es)
|
2016-06-08 |
2018-01-31 |
Abbvie Inc |
Anticuerpos anti-b7-h3 y conjugados de fármaco y anticuerpos
|
|
EP3478324A1
(en)
|
2016-07-01 |
2019-05-08 |
GlaxoSmithKline Intellectual Property (No.2) Limited |
Antibody-drug conjugates and therapeutic methods using the same
|
|
RU2653443C2
(ru)
*
|
2016-07-15 |
2018-05-08 |
Закрытое Акционерное Общество "Биокад" |
Биспецифичные анти-her2/анти-her3 антитела
|
|
EP4273172A3
(en)
|
2016-09-23 |
2024-02-28 |
Regeneron Pharmaceuticals, Inc. |
Bi specific anti-muc16-cd3 antibodies and anti-muc16 drug conjugates
|
|
MX2019003325A
(es)
|
2016-09-23 |
2019-08-05 |
Regeneron Pharma |
Anticuerpos anti-steap2, conjugados anticuerpo-farmaco, y moleculas de fijacion al antigeno biespecificas que se fijan a steap2 y cd3, y usos de estos.
|
|
MX394528B
(es)
|
2016-11-08 |
2025-03-24 |
Regeneron Pharma |
Esteroides y conjugados de proteinas de los mismos.
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
CN116813690A
(zh)
|
2016-11-23 |
2023-09-29 |
伊缪诺金公司 |
苯并二氮䓬衍生物的选择性磺化
|
|
KR20190091290A
(ko)
|
2016-11-29 |
2019-08-05 |
리제너론 파아마슈티컬스, 인크. |
Ｐｒｌｒ 양성 유방암 치료 방법
|
|
CN110234348B
(zh)
|
2016-12-16 |
2024-06-25 |
蓝鳍生物医药公司 |
抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
|
|
EP3558391B1
(en)
|
2016-12-23 |
2022-02-02 |
Immunogen, Inc. |
Immunoconjugates targeting adam9 and methods of use thereof
|
|
TW201825515A
(zh)
|
2017-01-04 |
2018-07-16 |
美商伊繆諾金公司 |
Ｍｅｔ抗體以及其免疫結合物及用途
|
|
CA3053749A1
(en)
|
2017-02-28 |
2018-09-07 |
Kinki University |
Method for treating egfr-tki-resistant non-small cell lung cancer by administration of anti-her3 antibody-drug conjugate
|
|
SG11201907693VA
(en)
|
2017-02-28 |
2019-09-27 |
Immunogen Inc |
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof
|
|
EP3381474A1
(en)
*
|
2017-03-27 |
2018-10-03 |
Alfasigma S.p.A. |
Histone deacetylase inhibitors-based antibody drug conjugates (adcs) and use in therapy
|
|
US11419946B2
(en)
|
2017-03-30 |
2022-08-23 |
Nof Corporation |
Heterobifunctional monodispersed polyethylene glycol and conjugate using same
|
|
TW201839001A
(zh)
|
2017-04-20 |
2018-11-01 |
美商伊繆諾金公司 |
細胞毒性苯并二氮平衍生物及其綴合物
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
AU2018269568B2
(en)
|
2017-05-18 |
2022-03-24 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
KR20250008984A
(ko)
|
2017-05-18 |
2025-01-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
EP3635009A1
(en)
|
2017-06-07 |
2020-04-15 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for internalizing enzymes
|
|
WO2018235024A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
SG11202004151YA
(en)
|
2017-11-07 |
2020-06-29 |
Regeneron Pharma |
Hydrophilic linkers for antibody drug conjugates
|
|
CN109771658B
(zh)
*
|
2017-11-14 |
2021-12-10 |
博瑞生物医药（苏州）股份有限公司 |
靶向多臂偶联物
|
|
TWI827575B
(zh)
|
2017-12-28 |
2024-01-01 |
美商伊繆諾金公司 |
苯二氮平衍生物
|
|
CA3086926A1
(en)
|
2018-01-08 |
2019-07-11 |
Regeneron Pharmaceuticals, Inc. |
Steroids and antibody-conjugates thereof
|
|
TW201934187A
(zh)
*
|
2018-01-12 |
2019-09-01 |
美商免疫遺傳股份有限公司 |
抗體藥物結合、純化、及調配之方法
|
|
MX2020011487A
(es)
|
2018-04-30 |
2020-12-07 |
Regeneron Pharma |
Anticuerpos y moleculas biespecificas de union al antigeno que se unen a her2 y/o aplp2, conjugados y usos de estos.
|
|
SG11202010909RA
(en)
|
2018-05-09 |
2020-12-30 |
Regeneron Pharma |
Anti-msr1 antibodies and methods of use thereof
|
|
EP3793591A1
(en)
|
2018-05-17 |
2021-03-24 |
Regeneron Pharmaceuticals, Inc. |
Anti-cd63 antibodies, conjugates, and uses thereof
|
|
EP3814378A1
(en)
|
2018-06-26 |
2021-05-05 |
ImmunoGen, Inc. |
Immunoconjugates targeting adam9 and methods of use thereof
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
US20220072144A1
(en)
|
2018-09-20 |
2022-03-10 |
Daiichi Sankyo Company, Limited |
Treatment of her3-mutated cancer by administration of anti-her3 antibody-drug conjugate
|
|
CN109350748B
(zh)
*
|
2018-10-24 |
2021-06-11 |
沈阳药科大学 |
氧化还原双敏感键桥连小分子前药及其自组装纳米粒
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
BR112021009673A2
(pt)
|
2018-11-20 |
2021-12-14 |
Regeneron Pharma |
Derivados de bis-octa-hidrofenantreno carboxamida e conjugados de proteínas dos mesmos para uso como agonistas de lxr
|
|
AU2019403404B2
(en)
|
2018-12-21 |
2025-05-29 |
Regeneron Pharmaceuticals, Inc. |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
MA53765B2
(fr)
|
2018-12-21 |
2025-04-30 |
Regeneron Pharmaceuticals, Inc. |
Tubulysines et conjugués tubulysines-protéines
|
|
CA3125998A1
(en)
|
2019-01-08 |
2020-07-16 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
|
CN113727757A
(zh)
|
2019-02-21 |
2021-11-30 |
瑞泽恩制药公司 |
使用结合met的抗-met抗体和双特异性抗原结合分子治疗眼癌的方法
|
|
ES3017207T3
(en)
|
2019-03-20 |
2025-05-12 |
Univ California |
Claudin-6 antibodies and drug conjugates
|
|
JP7682797B2
(ja)
|
2019-03-20 |
2025-05-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
クローディン６二重特異性抗体
|
|
TW202102506A
(zh)
|
2019-03-29 |
2021-01-16 |
美商伊繆諾金公司 |
苯二氮平衍生物
|
|
SG11202110922QA
(en)
|
2019-04-26 |
2021-10-28 |
Immunogen Inc |
Camptothecin derivatives
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
MX2022000450A
(es)
|
2019-07-10 |
2022-04-25 |
Cybrexa 3 Inc |
Conjugados peptídicos de agentes dirigidos a microtúbulos como terapéuticos.
|
|
PH12022550039A1
(en)
|
2019-07-10 |
2023-06-26 |
Cybrexa 3 Inc |
Peptide conjugates of cytotoxins as therapeutics
|
|
WO2021055350A1
(en)
|
2019-09-16 |
2021-03-25 |
Regeneron Pharmaceuticals, Inc. |
Radiolabeled met binding proteins for immuno-pet imaging
|
|
US11814428B2
(en)
|
2019-09-19 |
2023-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-PTCRA antibody-drug conjugates and uses thereof
|
|
KR20220131266A
(ko)
|
2020-01-24 |
2022-09-27 |
리제너론 파마슈티칼스 인코포레이티드 |
단백질-항바이러스 화합물 접합체
|
|
EP4110402A1
(en)
|
2020-02-25 |
2023-01-04 |
Mediboston, Inc. |
Camptothecin derivatives and conjugates thereof
|
|
CA3166619A1
(en)
|
2020-02-28 |
2021-09-02 |
Julian Andreev |
Bispecific antigen binding molecules that bind her2, and methods of use thereof
|
|
CA3179154A1
(en)
|
2020-04-16 |
2021-10-21 |
Regeneron Pharmaceuticals, Inc. |
Diels-alder conjugation methods
|
|
MA58646A1
(fr)
|
2020-06-24 |
2023-08-31 |
Regeneron Pharma |
Tubulysines et conjugués tubulysines-protéines
|
|
US20230256114A1
(en)
|
2020-07-07 |
2023-08-17 |
Bionecure Therapeutics, Inc. |
Novel maytansinoids as adc payloads and their use for the treatment of cancer
|
|
BR112023000489A2
(pt)
|
2020-07-13 |
2023-03-28 |
Regeneron Pharma |
Análogos de camptotecina conjugados a um resíduo de glutamina em uma proteína, e seu uso
|
|
KR20230041023A
(ko)
|
2020-07-17 |
2023-03-23 |
다이이찌 산쿄 가부시키가이샤 |
항체-약물 콘주게이트의 제조 방법
|
|
AU2021339892A1
(en)
|
2020-09-14 |
2023-04-27 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof
|
|
CA3190569A1
(en)
|
2020-10-22 |
2022-04-28 |
Christopher Daly |
Anti-fgfr2 antibodies and methods of use thereof
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US20220378929A1
(en)
|
2021-02-25 |
2022-12-01 |
MediBoston Limted |
Anti-her2 antibody-drug conjugates and uses thereof
|
|
EP4304658A4
(en)
|
2021-03-08 |
2025-03-12 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Antibody-immunagonist conjugate and applications thereof
|
|
WO2022218331A1
(en)
|
2021-04-14 |
2022-10-20 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Linkers, conjugates and applications thereof
|
|
US20250041433A1
(en)
|
2021-07-28 |
2025-02-06 |
Regeneron Pharmaceuticals, Inc. |
Protein-antiviral compound conjugates
|
|
US20240352199A1
(en)
*
|
2021-08-20 |
2024-10-24 |
Pusan National University Industry-University Cooperation Foundation |
Method for preparation of fixed swellable polymer
|
|
EP4448015A1
(en)
*
|
2021-12-15 |
2024-10-23 |
The Administrators of The Tulane Educational Fund |
Conjugates, their compositions, and their related methods
|
|
US20230414775A1
(en)
|
2021-12-29 |
2023-12-28 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
JP2025502147A
(ja)
|
2022-01-12 |
2025-01-24 |
リジェネロン ファーマシューティカルズ，インク． |
タンパク質中のグルタミン残基にコンジュゲートしたカンプトテシンアナログおよびその使用
|
|
JP2025503700A
(ja)
|
2022-01-14 |
2025-02-04 |
レジェネロン ファーマシューティカルズ， インコーポレイテッド |
ベルカリンａ誘導体及びその抗体薬物複合体
|
|
EP4489855A1
(en)
|
2022-03-11 |
2025-01-15 |
Regeneron Pharmaceuticals, Inc. |
Anti-glp1r antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof
|
|
AU2023310999A1
(en)
|
2022-07-21 |
2025-01-23 |
Firefly Bio, Inc. |
Glucocorticoid receptor agonists and conjugates thereof
|
|
US20240108744A1
(en)
|
2022-07-27 |
2024-04-04 |
Mediboston Limited |
Auristatin derivatives and conjugates thereof
|
|
EP4626553A2
(en)
|
2022-11-30 |
2025-10-08 |
Regeneron Pharmaceuticals, Inc. |
Tlr7 agonists and antibody-drug-conjugates thereof
|
|
AU2023407365A1
(en)
|
2022-12-21 |
2025-07-31 |
Regeneron Pharmaceuticals, Inc. |
Prodrugs of topoisomerase i inhibitor for adc conjugations and methods of use thereof
|
|
CN121001751A
(zh)
|
2023-02-09 |
2025-11-21 |
里珍纳龙药品有限公司 |
借助逆电子需求狄尔斯-阿尔德反应的抗体-药物缀合物
|
|
WO2024220628A1
(en)
*
|
2023-04-18 |
2024-10-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Target for combatting the foreign body response to implantable biomaterials
|
|
WO2024229105A1
(en)
|
2023-05-02 |
2024-11-07 |
Regeneron Pharmaceuticals, Inc. |
Anti-human m-cadherin (cdh15) antibodies, conjugates, and uses thereof for delivery of genetic payloads to muscle cells
|
|
WO2025014533A1
(en)
|
2023-07-10 |
2025-01-16 |
Regeneron Pharmaceuticals, Inc. |
Anti-human cacng1 antibody-drug conjugates and uses thereof
|
|
WO2025094146A1
(en)
|
2023-11-02 |
2025-05-08 |
Immunogen Switzerland Gmbh |
Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
|
|
WO2025096921A1
(en)
|
2023-11-03 |
2025-05-08 |
Regeneron Pharmaceuticals, Inc. |
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof
|
|
WO2025117727A1
(en)
|
2023-11-29 |
2025-06-05 |
Regeneron Pharmaceuticals, Inc. |
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof
|
|
CN118580194A
(zh)
*
|
2024-05-21 |
2024-09-03 |
南方科技大学 |
一种双功能分子探针的制备方法
|